Precigen (PGEN) Other Accumulated Expenses (2012 - 2026)
Precigen's (PGEN) quarterly Other Accumulated Expenses came in at $12.5 million in Q1 2026, up 90.03% year-on-year from $6.6 million in Q1 2025, and up 13.54% on a QoQ basis from $11.0 million in Q4 2025.
Precigen (PGEN) Other Accumulated Expenses (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Other Accumulated Expenses data on file, last reported at $12.5 million in Q1 2026.
- On a quarterly basis, Other Accumulated Expenses rose 90.03% year-over-year to $12.5 million in Q1 2026; TTM through Mar 2026 was $12.5 million, a 90.03% increase from a year earlier, with the FY2025 full-year figure at $11.0 million, up 128.45% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $12.5 million, up from $11.0 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for PGEN reached as high as $22.9 million in Q1 2023 and fell as low as $3.3 million in Q2 2023.
- Historically, Other Accumulated Expenses has averaged $8.7 million across 5 years, with a median of $7.3 million in 2024.
- Across the five-year window, Other Accumulated Expenses tumbled 68.12% in 2024 and soared 128.45% in 2025, its largest moves.
- Year by year, Other Accumulated Expenses stood at $5.0 million in 2022, then advanced by 24.53% to $6.2 million in 2023, then dropped by 22.67% to $4.8 million in 2024, then surged by 128.45% to $11.0 million in 2025, then gained by 13.54% to $12.5 million in 2026.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $12.5 million in Q1 2026, $11.0 million in Q4 2025, and $10.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.48 Mn |
| Dec 31, 2025 | 10.99 Mn |
| Sep 30, 2025 | 10.82 Mn |
| Jun 30, 2025 | 9.51 Mn |
| Mar 31, 2025 | 6.57 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Sep 30, 2024 | 5.68 Mn |
| Jun 30, 2024 | 6.64 Mn |
| Mar 31, 2024 | 7.30 Mn |
| Dec 31, 2023 | 6.22 Mn |
| Sep 30, 2023 | 4.12 Mn |
| Jun 30, 2023 | 3.26 Mn |
| Mar 31, 2023 | 22.89 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 11.69 Mn |
| Jun 30, 2022 | 9.67 Mn |
| Mar 31, 2022 | 10.49 Mn |
| Dec 31, 2021 | 7.82 Mn |
| Sep 30, 2021 | 11.26 Mn |
| Jun 30, 2021 | 10.47 Mn |